<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613938/" ref="ordinalpos=3521&amp;ncbi_uid=5670690&amp;link_uid=PMC3613938" image-link="/pmc/articles/PMC3613938/figure/F1/" class="imagepopup">Figure 1. Canonical WNT <span class="highlight" style="background-color:">signaling</span> determines the proliferation and differentiation state of ESC-derived progenitors via full-length TCF7 (fTCF7)..  From: WNT <span class="highlight" style="background-color:">signaling</span> in stem cell differentiation and tumor formation. </a></div><br /><div class="p4l_captionBody">SOX2 and NESTIN act as direct targets of fTCF7 in vitro. Blocking the pathway by deleting TCF7 or treating cells with the WNT inhibitor DKK1 could reduce tumorigenicity and improve therapeutic efficiency. Î”NTCF7, naturally truncated form of TCF7.</div></div>